CD8A and neoplasm: On the other hand, neutralizing eNAMPT with the monoclonal antibody C269 activated CD8+IFNγ+GRZB+ T cells and reduced the immunosuppressive phenotype of regulatory T cells, thereby restoring antitumoral immune responses, decreasing tumor size, and reducing the number of lung metastases in triple-negative breast cancer [28].